AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 97 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $5,007,000 | +246.7% | 150,000 | +233.3% | 0.22% | +309.1% |
| Q2 2014 | $1,444,000 | -87.0% | 45,000 | -81.2% | 0.06% | -90.3% |
| Q1 2014 | $11,081,000 | -85.0% | 240,000 | -76.9% | 0.57% | -83.2% |
| Q4 2013 | $73,658,000 | -52.0% | 1,038,410 | -42.0% | 3.38% | -55.2% |
| Q3 2013 | $153,403,000 | +58.8% | 1,789,181 | +35.0% | 7.53% | +31.9% |
| Q2 2013 | $96,584,000 | – | 1,324,847 | – | 5.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |